Patent ID: 9707251
Date: 2017-07-18
CPC Classifications: A61K,A61L,A61P

Claim:
1. A two-fluid component injection device for in situ formation of a soft solid artificial blockage to control moderate to severe bleeding, the two-fluid component injection device comprising two isolated chambers, wherein the two isolated chambers comprise a first isolated chamber and a second isolated chamber, the two-fluid component injection device comprising: a) the first isolated chamber comprising a first fluid component, the first fluid component comprising: b) the second isolated chamber comprising a second fluid component, the second fluid component comprising: wherein the device comprises a mixing tip for mixing the first fluid component and the second fluid component in the two-fluid component injection device to form an active hemostatic dressing, the active hemostatic dressing being injectable into a wound to form the soft solid artificial blockage within the wound, wherein the first fluid component and the second fluid component are kept separately within the two isolated chambers of the two-fluid component injection device until mixed within the mixing tip for application into the wound, wherein the iron oxides in the mixture function as negative co-catalysts in the decomposition of hydrogen peroxide, wherein the siloxane polymer curing agent in the first fluid component is selected from the group consisting of platinum, tin, palladium, rhodium, and respective compounds, salts, complexes thereof, and a combination thereof, wherein the soft solid artificial blockage conforms to irregular wound surfaces, and the hydrogen peroxide in the soft solid artificial blockage is less than 5% by weight or volume.